What is Tandem Diabetes Care Intrinsic Value: Projected FCF?
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
The historical rank and industry rank for Tandem Diabetes Care's Intrinsic Value: Projected FCF or its related term are showing as below:
TNDM'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 7.55 Med: 7.86 Max: 38.79
Current: 11.41
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Tandem Diabetes Care was 38.79. The lowest was 7.55. And the median was 7.86.
TNDM's Price-to-Projected-FCF is ranked worse than 95.42% of 349
companies
in the Medical Devices & Instruments industry
Industry Median: 1.7
vs TNDM: 11.41
Tandem Diabetes Care Intrinsic Value: Projected FCF Historical Data
The historical data trend for Tandem Diabetes Care's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Tandem Diabetes Care Intrinsic Value: Projected FCF Chart
Competitive Comparison of Tandem Diabetes Care's Intrinsic Value: Projected FCF
For the Medical Devices subindustry, Tandem Diabetes Care's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tandem Diabetes Care's Price-to-Projected-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tandem Diabetes Care's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Tandem Diabetes Care's Price-to-Projected-FCF falls into.
Tandem Diabetes Care Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tandem Diabetes Care (NAS:TNDM) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Tandem Diabetes Care's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
44.72
/
3.9224672340366
=
11.40
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tandem Diabetes Care Intrinsic Value: Projected FCF Related Terms
Thank you for viewing the detailed overview of Tandem Diabetes Care's Intrinsic Value: Projected FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Tandem Diabetes Care (Tandem Diabetes Care) Business Description
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. Nearly three quarters of total revenue is derived from the U.S., with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TNDM has been successfully added to your 